Potent early immune response after kidney transplantation in patients of the European senior transplant program

Transplantation

Volumn 87, Issue 7, 2009, Pages 992-1000

  Pratschke, Johann ^a   Merk, Vera ^a   Reutzel Selke, Anja ^a   Pascher, Andreas ^a   Denecke, Christian ^a   Lun, Andreas ^a   Said, Ali ^a   Schönemann, Constanze ^a   Ulrich, Frank ^a   Reinke, Petra ^a   Frei, Ulrich ^a   Neuhaus, Peter ^a   Tullius, Stefan G ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

European Senior Program; Immune response; Kidney transplantation

Indexed keywords

2 CYANO 3 HYDROXY N [4 (TRIFLUOROMETHYL)PHENYL] 6 HEPTYNAMIDE; ALEMTUZUMAB; AZATHIOPRINE; BASILIXIMAB; CALCINEURIN INHIBITOR; CYCLOSPORIN A; DACLIZUMAB; FINGOLIMOD; INFLIXIMAB; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ANTIBODY; INTERLEUKIN 4; INTERLEUKIN 5; LYMPHOCYTE SURFACE MARKER; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; RAPAMYCIN; STEROID; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA; GAMMA INTERFERON; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN DERIVATIVE;

ADULT; AGE; AGED; AGING; ARTICLE; CYTOKINE PRODUCTION; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEMORY T LYMPHOCYTE; PLASMAPHERESIS; PRIORITY JOURNAL; ALLOTRANSPLANTATION; BLOOD; DONOR; FLOW CYTOMETRY; GERMANY; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; IMMUNOLOGY; MIDDLE AGED;

ADULT; AGE FACTORS; AGED; BERLIN; FEMALE; FLOW CYTOMETRY; GERMANY; GLUCOCORTICOIDS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON-GAMMA; INTERLEUKINS; KIDNEY TRANSPLANTATION; MALE; METHYLPREDNISOLONE; MIDDLE AGED; TISSUE DONORS; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION, HOMOLOGOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 65549124916     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31819ca0d7     Document Type: Article

References (35)

1. Cecka JM. The OPTN/UNOS Renal Transplant Registry 2005. Clin Transpl 2005: 1.
2. Port FK, Bragg-Gresham JL, Metzger RA, et al. Donor characteristics associated with reduced graft survival: An approach to expanding the pool of kidney donors. Transplantation 2002; 74: 1281.
3. Terasaki PI, Gjertson DW, Cecka JM, et al. Significance of the donor age effect on kidney transplants. Clin Transpl 1997; 11: 366.
4. Basar H, Soran A, Shapiro R, et al. Renal transplantation in recipients over the age of 60: The impact of donor age. Transplantation 1999; 67: 1191.
5. de Fijter JW, Mallat MJ, Doxiadis II, et al. Increased immunogenicity and cause of graft loss of old donor kidneys. J Am Soc Nephrol 2001; 12: 1538.
6. Bradley BA. Does the risk of acute rejection really decrease with increasing recipient age? Transpl Int 2000; 13(suppl 1): S42.
7. Jassal SV, Opelz G, Cole E. Transplantation in the elderly: A review. Geriatr Nephrol Urol 1997; 7: 157.
8. Waiser J, Schreiber M, Budde K, et al. Age-matching in renal transplantation. Nephrol Dial Transplant 2000; 15: 696.
9. Cecka JM, Terasaki PI. Optimal use for older donor kidneys: Older recipients. Transplant Proc 1995; 27: 801.
10. Meier-Kriesche HU, Ojo AO, Cibrik DM, et al. Relationship of recipient age and development of chronic allograft failure. Transplantation 2000; 70: 306.
11. Liu S, Lutz J, Antus B, et al. Recipient age and weight affect chronic renal allograft rejection in rats. J Am Soc Nephrol 2001; 12: 1742.
12. Lufft V, Kliem V, Tusch G, et al. Renal transplantation in older adults: Is graft survival affected by age? A case control study. Transplantation 2000; 69: 790.
13. Pascher A, Reutzel-Selke A, Jurisch A, et al. Alterations of the immune response with increasing recipient age are associated with reduced long-term organ graft function of rat kidney allografts. Transplantation 2003; 76: 1560.
14. Smits JM, Persijn GG, van Houwelingen HC, et al. Evaluation of the Eurotransplant Senior Program. The results of the first year. Am J Transplant 2002; 2: 664.
15. Theodorakis J, Schneeberger H, Illner WD, et al. Nephrotoxicity-free, mycophenolate mofetil-based induction/maintenance immunosuppression in elderly recipients of renal allografts from elderly cadaveric donors. Transplant Proc 2000; 32: 9S.
16. Land WG. Ageing and immunosuppression in kidney transplantation. Exp Clin Transplant 2004; 2: 229.
17. Emparan C, Wolters H, Laukotter M, et al. Long-term results of calcineurin-free protocols with basiliximab induction in "old-to-old" programs. Transplant Proc 2004; 36: 2646.
18. Giessing M, Budde K, Fritsche L, et al. "Old-for-old" cadaveric renal transplantation: Surgical findings, perioperative complications and outcome. Eur Urol 2003; 44: 701.
19. Giessing M, Conrad S, Schonberger B, et al. [Kidney donors and kidney transplantation in the elderly]. Urologe A 2004; 43: 947.
20. Voiculescu A, Schlieper G, Hetzel GR, et al. Kidney transplantation in the elderly: Age-matching as compared to HLA-matching: A single center experience. Transplantation 2002; 73: 1356.
21. Pawelec G, Wagner W, Adibzadeh M, et al. T cell immunosenescence in vitro and in vivo. Exp Gerontol 1999; 34: 419.
22. Pawelec G, Barnett Y, Forsey R, et al. T cells and aging, January 2002 update. Front Biosci 2002; 7: d1056.
23. Sidman CL, Luther EA, Marshall JD, et al. Increased expression of major histocompatibility complex antigens on lymphocytes from aged mice. Proc Natl Acad Sci USA 1987; 84: 7624.
24. Castle SC, Uyemura K, Crawford W, et al. Antigen presenting cell function is enhanced in healthy elderly. Mech Ageing Dev 1999; 107: 137.
25. Heeger PS, Greenspan NS, Kuhlenschmidt S, et al. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol 1999; 163: 2267.
26. Hricik DE, Rodriguez V, Riley J, et al. Enzyme linked immunosorbent spot (ELISPOT) assay for interferon-gamma independently predicts renal function in kidney transplant recipients. Am J Transplant 2003; 3: 878.
27. Gebauer BS, Hricik DE, Atallah A, et al. Evolution of the enzyme-linked immunosorbent spot assay for post-transplant alloreactivity as a potentially useful immune monitoring tool. Am J Transplant 2002; 2: 857.
28. Nickel P, Presber F, Bold G, et al. Enzyme-linked immunosorbent spot assay for donor-reactive interferon-gamma-producing cells identifies T-cell presensitization and correlates with graft function at 6 and 12 months in renal-transplant recipients. Transplantation 2004; 78: 1640.
29. Bruunsgaard H. Effects of tumor necrosis factor-alpha and interleukin-6 in elderly populations. Eur Cytokine Netw 2002; 13: 389.
30. Bathgate AJ, Lee P, Hayes PC, et al. Pretransplantation tumor necrosis factor-alpha production predicts acute rejection after liver transplantation. Liver Transpl 2000; 6: 721.
31. Hill GR, Teshima T, Rebel VI, et al. The p55 TNF-alpha receptor plays a critical role in T cell alloreactivity. J Immunol 2000; 164: 656.
32. Frei U, Noeldeke J, Machold-Fabrizii V, et al. Prospective age-matching in elderly kidney transplant recipients-A 5-year analysis of the Eurotransplant Senior Program. Am J Transplant 2008; 8: 50.
33. de Fijter JW, Persijn GG. Age, the riddle of renal transplantation. Nephrol Dial Transplant 2005; 20: 2307.
34. Reutzel-Selke A, Jurisch A, Denecke C, et al. Donor age intensifies the early immune response after transplantation. Kidney Int 2007; 71: 629.
35. Guba M, Rentsch M, Wimmer CD, et al. Calcineurin-inhibitor avoidance in elderly renal allograft recipients using ATG and basiliximab combined with mycophenolate mofetil. Transpl Int 2008; 21: 637.